Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Pulmatrix stock

Learn how to easily invest in Pulmatrix stock.

Pulmatrix Inc is a biotechnology business based in the US. Pulmatrix shares (PULM) are listed on the NASDAQ and all prices are listed in US Dollars. Pulmatrix employs 20 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Pulmatrix

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – PULM – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Pulmatrix stock price (NASDAQ: PULM)

Use our graph to track the performance of PULM stocks over time.

Pulmatrix shares at a glance

Information last updated 2022-01-17.
Latest market close$0.40
52-week range$0.39 - $3.04
50-day moving average $0.59
200-day moving average $0.82
Wall St. target price$5.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.39

Buy Pulmatrix shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stocks, Options, ETFs
$0 per year
Get a free stock valued up to $3500
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
$125 - $625
Open and fund an account with $25,000 - $250,000+

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Pulmatrix stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Pulmatrix price performance over time

Historical closes compared with the close of $0.399 from 2022-01-14

1 week (2022-01-08) N/A
1 month (2021-12-17) -16.00%
3 months (2021-10-19) -45.33%
6 months (2021-07-19) -55.17%
1 year (2021-01-19) -70.44%
2 years (2020-01-17) -75.52%
3 years (2019-01-18) 63.12%
5 years (2017-01-19) 0.9201

Pulmatrix financials

Revenue TTM $6.7 million
Gross profit TTM $-2,975,000
Return on assets TTM -19.28%
Return on equity TTM -55.43%
Profit margin -283.61%
Book value $0.80
Market capitalisation $22.4 million

TTM: trailing 12 months

Pulmatrix share dividends

We're not expecting Pulmatrix to pay a dividend over the next 12 months.

Have Pulmatrix's shares ever split?

Pulmatrix's shares were split on a 1:10 basis on 5 February 2019. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Pulmatrix shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Pulmatrix shares which in turn could have impacted Pulmatrix's share price.

Pulmatrix share price volatility

Over the last 12 months, Pulmatrix's shares have ranged in value from as little as $0.385 up to $3.04. A popular way to gauge a stock's volatility is its "beta".

PULM.US volatility(beta: 1.19)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Pulmatrix's is 1.1921. This would suggest that Pulmatrix's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Pulmatrix overview

Pulmatrix, Inc. , a clinical stage biopharmaceutical company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company focuses on developing products based on its inhaled Small Particles Easily Respirable and Emitted (iSPERSE) technology, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing Pulmazole, an inhaled anti-fungal drug that is in Phase 2b clinical trials for the prevention and treatment of fungal infections and allergic/hypersensitivity reactions to fungus in patients with severe lung diseases comprising asthma, cystic fibrosis, and allergic bronchopulmonary aspergillosis; PUR1800, a narrow spectrum kinase inhibitor that is in Phase 1b clinical trials for patients with lung cancer and chronic obstructive pulmonary disease; and PUR3100, an iSPERSE formulation of dihydroergotamine for the treatment of acute migraine. The company has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates; a development and commercialization agreement with Cipla Technologies LLC for the development and commercialization of Pulmazole; and a collaboration and license agreement with Sensory Cloud, Inc. Pulmatrix, Inc.

Frequently asked questions

What percentage of Pulmatrix is owned by insiders or institutions?
Currently 0.003% of Pulmatrix shares are held by insiders and 30.285% by institutions.
How many people work for Pulmatrix?
Latest data suggests 20 work at Pulmatrix.
When does the fiscal year end for Pulmatrix?
Pulmatrix's fiscal year ends in December.
Where is Pulmatrix based?
Pulmatrix's address is: 99 Hayden Avenue, Lexington, MA, United States, 02421
What is Pulmatrix's ISIN number?
Pulmatrix's international securities identification number is: US74584P2020
What is Pulmatrix's CUSIP number?
Pulmatrix's Committee on Uniform Securities Identification Procedures number is: 74584P103

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site